MEI Pharma logo
MEI Pharma MEIP
report update icon

Quarterly report 2027-Q1
added 11-05-2026

MEI Pharma ROCE Ratio | MEIP

Annual ROCE Ratio MEI Pharma

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002
-159.95 -103.09 44.04 -36.59 -49.21 -39.27 -13.11 -67.65 -29.54 4.69 -50.43 -54.81 -60.25 -32.18 -182.52 -359.59 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
44.04 -359.59 -74.34

Quarterly ROCE Ratio MEI Pharma

2027-Q1 2026-Q4 2026-Q3 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-43.6 -69.22 -105.71 -71.01 -111.5 -113.25 -93.68 -30.7 14.9 98.79 122.86 15.5 16.82 -63.77 -80.35 -45.64 -45.14 -42.52 -41.74 -35.26 -19.34 -23.72 -27.52 -42.46 -65.5 -68.12 -69.54 -59.24 -49.78 -40.0 -33.2 -31.57 -32.58 -26.54 1.46 -9.41 -14.66 -22.22 -52.69 -42.67 -37.27 -36.8 -35.84 -33.23 -44.83 -60.47 -72.07 -84.22 -82.25 -74.08 -72.11 -66.27 -107.99 -182.72 -208.95 -248.48 -238.4 -205.52 -377.92 -432.04 -57.62 -216.83 -107.75

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
122.86 -432.04 -72.02

ROCE Ratio of other stocks in the Biotechnology industry

Issuer ROCE Ratio Price % 24h Market Cap Country
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
15.18 - - - russiaRussia
Lyra Therapeutics Lyra Therapeutics
LYRA
289.47 - - $ 24.9 M usaUSA
Brickell Biotech Brickell Biotech
BBI
-64.05 - -5.38 % $ 6.06 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
-175.6 - - $ 8.42 M usaUSA
ESSA Pharma ESSA Pharma
EPIX
-29.63 - - $ 8.86 M canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
-165.18 - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
74.33 - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
-41.99 - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
-71.67 - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
-92.11 $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-17.17 - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
-46.69 - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
9.07 - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-5.84 - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-168.29 - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
-68.09 $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
-90.77 $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
-25.89 - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
-134.09 - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
-46.52 - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
-1610.96 - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
-106.49 - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
-60.71 - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
-69.47 - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-883.35 - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
-235.23 - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-36.31 - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
-35.83 - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
-34.9 - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
-53.23 - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
11.01 - - $ 109 M usaUSA
Akouos Akouos
AKUS
-37.16 - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
-141.76 - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
-96.98 - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
-106.57 - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
458.12 - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
1322.0 - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
166.56 - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
102.23 - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
-242.78 - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
19.77 - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-70.32 - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
-194.9 - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
-71.49 - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
-59.84 - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
545.12 - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
-111.56 - - $ 728 M usaUSA